BSE Live
Nov 25, 16:01Prev. Close
96.20
Open Price
96.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 25, 15:56Prev. Close
96.28
Open Price
96.30
Bid Price (Qty.)
99.93 (2)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Brooks Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -3.72 | -7.65 | -12.57 | -7.82 | -7.84 | |
| Diluted EPS (Rs.) | -3.72 | -7.65 | -12.57 | -7.82 | -7.84 | |
| Cash EPS (Rs.) | 1.57 | 1.26 | -8.39 | -4.84 | -4.95 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 33.30 | 24.99 | 29.94 | 54.37 | 32.04 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 33.30 | 24.99 | 29.94 | 54.37 | 32.04 | |
| Revenue from Operations/Share (Rs.) | 28.03 | 30.28 | 25.59 | 36.87 | 31.27 | |
| PBDIT/Share (Rs.) | 1.98 | 1.59 | -10.61 | -5.44 | 0.51 | |
| PBIT/Share (Rs.) | 1.43 | 0.91 | -13.46 | -8.42 | -2.38 | |
| PBT/Share (Rs.) | 1.08 | 0.59 | -14.20 | -9.67 | -3.64 | |
| Net Profit/Share (Rs.) | 1.02 | 0.58 | -11.23 | -7.82 | -7.84 | |
| NP After MI And SOA / Share (Rs.) | -3.38 | -7.46 | -8.46 | -6.55 | -7.84 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.05 | 5.24 | -41.47 | -14.76 | 1.62 | |
| PBIT Margin (%) | 5.11 | 3.01 | -52.59 | -22.83 | -7.62 | |
| PBT Margin (%) | 3.86 | 1.95 | -55.48 | -26.23 | -11.63 | |
| Net Profit Margin (%) | 3.65 | 1.92 | -43.89 | -21.20 | -25.07 | |
| NP After MI And SOA Margin (%) | -12.07 | -24.64 | -33.06 | -17.77 | -25.08 | |
| Return on Networth/Equity (%) | -10.15 | -29.87 | -28.26 | -25.67 | -24.47 | |
| Return on Capital Employed (%) | 4.18 | 3.56 | -43.41 | -14.14 | -5.98 | |
| Return on Assets (%) | -8.05 | -21.66 | -19.06 | -8.26 | -11.95 | |
| Total Debt/Equity (X) | 0.06 | 0.08 | 0.08 | 0.38 | 0.35 | |
| Asset Turnover Ratio (%) | 0.77 | 0.79 | 0.41 | 0.58 | 47.66 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.48 | 1.35 | 0.84 | 1.25 | 0.79 | |
| Quick Ratio (X) | 1.08 | 0.93 | 0.49 | 0.69 | 0.42 | |
| Inventory Turnover Ratio (X) | 8.78 | 4.28 | 2.14 | 2.31 | 3.27 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 5.66 | 4.94 | -12.01 | -4.34 | 0.41 | |
| Interest Coverage Ratios (Post Tax) (%) | 5.66 | 4.94 | -12.01 | -4.34 | 0.41 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 322.19 | 247.92 | 159.23 | 271.01 | 179.90 | |
| EV/Net Operating Revenue (X) | 3.90 | 3.12 | 2.52 | 2.98 | 2.33 | |
| EV/EBITDA (X) | 55.34 | 59.41 | -6.07 | -20.15 | 143.19 | |
| MarketCap/Net Operating Revenue (X) | 3.84 | 3.06 | 2.45 | 1.97 | 1.99 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.24 | 3.71 | 2.09 | 2.84 | 1.94 | |
| Price/Net Operating Revenue | 3.84 | 3.06 | 2.45 | 1.97 | 1.99 | |
| Earnings Yield | -0.03 | -0.08 | -0.14 | -0.09 | -0.13 |
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y